Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 6 min ago
Peer-reviewedCC BYDiagnostics (Basel, Switzerland)

Survival Outcomes in Transthyretin Cardiac Amyloidosis in the Tafamidis Era: Real-World Evidence from Greece

  • Freideriki Eleni Kourti1
  • Alexios S. Antonopoulos1
  • Vasileios Kytinos1
  • Theodoros Tsampras1
  • Alexandrina Kouroutzoglou1
  • Dimitrios Kyriakopoulos1
  • Maria Eleni Koilakou1
  • Pinelopi Karampina2
  • Vasiliki Gardikioti1
  • Dimitrios Terentes-Printzios1
  • Alexandros Kasiakogias1
  • Ioannis Leontsinis1
5 more authors
  • Christina Chrysohoou1
  • Maria Koutelou3
  • Konstantinos Toutouzas1
  • Konstantinos Tsioufis1
  • Charalambos Vlachopoulos1
  1. 1Cardiogenetics Unit, National Cardiac Amyloidosis Centre, 1st Cardiology Department, Hippokration Hospital, , 11527 Athens, Greece
  2. 2Department of Nuclear Medicine, Kosmoiatriki, 11254 Athens, Greece
  3. 3Department of Nuclear Medicine, Bioiatriki, 11526 Athens, Greece
Read full textPDFCite

Related

  1. One-minute heart rate recovery and clinical outcomes in transthyretin cardiac amyloidosis: incremental model fit beyond conventional CPET indices
    Antonio Kösters, Nikita Ermolaev, Mahshid Eslami +5
    European heart journal openPeer-reviewedCC BYFull textCardiovascular medicineEurope PMCPMC
  2. Contrasting Echocardiographic Trajectories with and Without Tafamidis in Wild-Type Transthyretin Amyloid Cardiomyopathy: A Real-World Observational Study with Two-Dimensional Speckle-Tracking Analysis
    Inés Ramos González-Cristóbal, Irene Marco Clement, Ana Paola Espinoza +7
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Closing the diagnostic gap in transthyretin cardiac amyloidosis: red flags, modern imaging, and emerging therapies
    Zhengjun Yi, Peng Li, Xueqian Wang
    Frontiers in cardiovascular medicinePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  4. How to individualize device therapy in transthyretin cardiac amyloidosis: A dyssynchrony-based case report.
    Ahmet Taha Sahin, Ahmet Lutfu Sertdemir, Yakup Alsancak +2
    HeartRhythm case reportsPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  5. Delayed Diagnosis of Hereditary Transthyretin Cardiac Amyloidosis Presenting with Autonomic Neuropathy: A Case Report
    Bingjie Song, Qijun Zhang, Lei Tao +2
    Journal of cardiovascular development and diseasePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{kourti2026survival,
  title = {{Survival Outcomes in Transthyretin Cardiac Amyloidosis in the Tafamidis Era: Real-World Evidence from Greece}},
  author = {Freideriki Eleni Kourti and Alexios S. Antonopoulos and Vasileios Kytinos and Theodoros Tsampras and Alexandrina Kouroutzoglou and Dimitrios Kyriakopoulos and Maria Eleni Koilakou and Pinelopi Karampina and Vasiliki Gardikioti and Dimitrios Terentes-Printzios and Alexandros Kasiakogias and Ioannis Leontsinis and Christina Chrysohoou and Maria Koutelou and Konstantinos Toutouzas and Konstantinos Tsioufis and Charalambos Vlachopoulos},
  journal = {Diagnostics (Basel, Switzerland)},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13703235},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Survival Outcomes in Transthyretin Cardiac Amyloidosis in the Tafamidis Era: Real-World Evidence from Greece
AU  - Freideriki Eleni Kourti
AU  - Alexios S. Antonopoulos
AU  - Vasileios Kytinos
AU  - Theodoros Tsampras
AU  - Alexandrina Kouroutzoglou
AU  - Dimitrios Kyriakopoulos
AU  - Maria Eleni Koilakou
AU  - Pinelopi Karampina
AU  - Vasiliki Gardikioti
AU  - Dimitrios Terentes-Printzios
AU  - Alexandros Kasiakogias
AU  - Ioannis Leontsinis
AU  - Christina Chrysohoou
AU  - Maria Koutelou
AU  - Konstantinos Toutouzas
AU  - Konstantinos Tsioufis
AU  - Charalambos Vlachopoulos
PY  - 2026
DA  - 2026/10/01
JO  - Diagnostics (Basel, Switzerland)
UR  - https://europepmc.org/article/PMC/PMC13703235
SN  - 2075-4418
ER  -